This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vermeer, F. Articles by van der Laarse, A. Search for Related Content PubMed PubMed Citation Articles by Vermeer, F. Articles by van der Laarse, A.

Circulation, Vol 74, 1379-1389, Copyright © 1986 by American Heart Association

ARTICLES

Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? [published erratum appears in Circulation 1987 Feb;75(2):394]

F Vermeer, ML Simoons, FW Bar, JG Tijssen, RT van Domburg, PW Serruys, FW Verheugt, JC Res, C de Zwaan and A van der Laarse

The effect of thrombolysis in acute myocardial infarction on enzymatic infarct size, left ventricular function, and early mortality was studied in subsets of patients in a randomized trial. Early thrombolytic therapy with intracoronary streptokinase (152 patients) or with intracoronary streptokinase preceded by intravenous streptokinase (117 patients) was compared with conventional treatment (264 patients). All 533 patients were admitted to the coronary care unit within 4 hr after onset of symptoms indicative of acute myocardial infarction. Four hundred eighty-eight patients were eligible for this detailed analysis, and 245 of these were allocated to thrombolytic therapy and 243 to conventional treatment. Early angiographic examinations were performed in 212 patients allocated to thrombolytic therapy. Patency of the infarct-related artery was achieved in 181 patients (85%). Enzymatic infarct size, as measured from cumulative alpha-hydroxybutyrate dehydrogenase release, was smaller in patients allocated to thrombolytic therapy (median 760 vs 1170 U/liter in control patients, p = .0001). Left ventricular ejection fraction measured by radionuclide angiography before discharge from the hospital was higher after thrombolytic therapy (median 50% vs 43% in control patients, p = .0001). Three month mortality was lower in patients allocated to thrombolytic therapy (6% vs 14% in the control group, p = .006). With the use of multivariate regression analysis, infarct size limitation, improvement in left ventricular ejection fraction, and three month mortality were predicted by sum of the ST segment elevation, time from onset of symptoms to admission, and Killip class at admission. Thrombolysis was most effective in patients admitted within 2 hr after onset of symptoms and in patients with a sum of ST segment elevation of 1.2 mV or more. On the other hand, no beneficial effects of streptokinase on enzymatic infarct size, left ventricular function, or mortality were observed in the subset of patients with a sum of ST segment elevation of less than 1.2 mV who were admitted between 2 and 4 hr after onset of symptoms.

This article has been cited by other articles:

				M Toma, Y Fu, G Wagner, S G Goodman, C Granger, L Wallentin, F Van de Werf, and P Armstrong Risk stratification in ST-elevation myocardial infarction is enhanced by combining baseline ST deviation and subsequent ST-segment resolution Heart, March 1, 2008; 94(3): e6 - e6. [Abstract] [Full Text] [PDF]

				Y Birnbaum and B J Drew The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis Postgrad. Med. J., September 1, 2003; 79(935): 490 - 504. [Abstract] [Full Text]

				F. Mauri, M. G. Franzosi, A. P. Maggioni, E. Santoro, and L. Santoro Clinical value of 12-lead electrocardiography to predict the long-term prognosis of gissi-1 patients J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1594 - 1600. [Abstract] [Full Text] [PDF]

				F. Bar, J. Vainer, J. Stevenhagen, K. Neven, R. Aalbregt, T. Oude Ophuis, V. van Ommen, H. de Swart, E. de Muinck, W. Dassen, et al. Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction J. Am. Coll. Cardiol., July 1, 2000; 36(1): 51 - 58. [Abstract] [Full Text] [PDF]

				M. Kondo, A. Nakano, D. Saito, and Y. Shimono Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction J. Am. Coll. Cardiol., October 1, 1998; 32(4): 898 - 903. [Abstract] [Full Text] [PDF]

				R. L White Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update Asian Cardiovasc Thorac Ann, March 1, 1998; 6(1): 03 - 10. [Abstract] [Full Text] [PDF]

				J. Kellett and J. Clarke Comparison of "Accelerated" Tissue Plasminogen Activator with Streptokinase for Treatment of Suspected Myocardial Infarction Med Decis Making, October 1, 1995; 15(4): 297 - 310. [Abstract] [PDF]